|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/397 | |
| A61K 31/4704 | |||
| A61P 37/00 |
| (11) | Patento numeris | 3206682 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15784974.6 |
| Europos patento paraiškos padavimo data | 2015-10-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2015/057870 |
| Data | 2015-10-14 |
| (87) | Numeris | WO 2016/059571 |
| Data | 2016-04-21 |
| (30) | Numeris | Data | Šalis |
| 201462064537 P | 2014-10-16 | US |
| (72) |
SMITH, Paul Alfred, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS |
| COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS |